Biggest changeThese risks and uncertainties include, among others: • Changes in economic conditions and consumer sentiment and related impacts on discretionary consumer spending; • Increases in interest rates, which have increased the cost of servicing the Company’s indebtedness; • Availability of attractive and cost-effective consumer credit options; • Ability to achieve savings and efficiencies from cost savings plans related to business restructuring actions and to avoid unexpected adverse effects; • Dependence on, and ability to maintain working relationships with key suppliers and third parties; • Fluctuations in commodity costs or third-party delivery or logistics costs and other inflationary pressures; • Risks inherent in global-sourcing activities, including tariffs, foreign regulation, geo-political turmoil, war, pandemics, labor challenges, foreign currency fluctuations, inflation, and climate or other disasters, and resulting supply shortages and production and delivery delays and disruptions; • Operating with minimal levels of inventory, which may leave the Company vulnerable to supply shortages; • The effectiveness of the Company’s marketing strategy and promotional efforts; • The execution of Sleep Number’s Total Retail distribution strategy; • Ability to achieve and maintain high levels of product quality and to improve and expand the product line; • Ability to protect the Company’s technology, trademarks, and brand and the adequacy of its intellectual property rights; • Ability to effectively compete; • Risks of disruption in the operation of any of the Company’s facilities and operations, including manufacturing, assembly, distribution, logistics, field services, home delivery, headquarters, product development, retail or customer service operations; • Ability to comply with existing and changing government regulations and laws; • Pending or unforeseen litigation and the potential for associated adverse publicity; • The adequacy of the Company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems; • The Company’s ability to identify and withstand cyber threats that could compromise the security of its systems, result in a data breach or business disruption; • Risks associated with advancements in or adoption of artificial intelligence technologies; • Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified and effective personnel; • The volatility of Sleep Number stock, its removal from various stock indices, and the potential negative effects of shareholder activism or of changes in coverage by securities analysts; • Environmental, social and governance risks, including increasing regulation and stakeholder expectations; and • The Company’s ability to adapt to climate change and readiness for legal or regulatory responses thereto. 41 | 2023 FORM 10-K SLEEP NUMBER CORPORATION Additional information concerning these and other risks and uncertainties is contained under the caption “Risk Factors” in this Annual Report on Form 10-K.
Biggest changeThese risks and uncertainties include, among others: • Changes in economic conditions and consumer sentiment and related impacts on discretionary consumer spending; • Interest rates remain elevated, and may further increase and impact the cost of servicing the Company’s indebtedness; • Access to alternative financing options may depend on factors beyond the Company’s control or require the Company to accept unfavorable terms; • Availability of attractive and cost-effective consumer credit options; • Ability to achieve cost savings, efficiencies and other benefits from its business restructuring actions and to avoid adverse effects; • Effectiveness and efficiency of the Company’s marketing strategy and promotions; • Ability to execute Sleep Number’s Total Retail distribution strategy; • Ability to compete effectively; • Ability to achieve and maintain high levels of product and service quality; • Ability to improve and expand the product line and execute new product introductions; • Ability to protect the Company’s technology, trademarks and brand, and the adequacy of its intellectual property rights; • Dependence on, and ability to maintain working relationships with key suppliers and third parties, including some that are the only source of supply or services currently used by the Company; • Fluctuations in commodity costs or third-party delivery or logistics costs and other inflationary pressures; • Risks inherent in global-sourcing activities, including tariffs, foreign regulation, geo-political turmoil, war, pandemics, labor challenges, foreign currency fluctuations, inflation, climate or other disasters and resulting supply shortages, and production and delivery delays and disruptions; • Operating with minimal levels of inventory, which may leave the Company vulnerable to supply shortages; • Risks of disruption in the operation of any of the Company’s facilities and operations, including manufacturing, assembly, distribution, logistics, field services, home delivery, headquarters, product development, retail or customer service operations; • Ability to effectively complete potential future acquisitions and business combinations; • Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified and effective personnel; • Ability to comply with existing and changing government regulations and laws, and to commercialize new products and innovations that meet those existing and changing government regulations and laws; • Ability to identify and withstand cyber threats that could compromise the security of the Company’s systems or those of third parties upon which it relies and could result in a data breach or business disruption; • Risks associated with advancements in or adoption of artificial intelligence technologies; 37 | 2024 FORM 10-K SLEEP NUMBER CORPORATION • Adequacy of the Company’s and third-party information systems, and costs and disruptions related to upgrading or maintaining these systems; • Volatility of Sleep Number stock, its removal from various stock indices and the potential negative effects of shareholder activism or of changes in coverage by securities analysts; • Unfavorable tax treatment; • Environmental, social and governance risks, including increasing scrutiny and evolving regulatory and stakeholder expectations; and • Ability to adapt to climate change and readiness for legal or regulatory responses thereto.
The Company’s MD&A is presented in the following sections: • Overview • Results of Operations • Liquidity and Capital Resources • Critical Accounting Policies and Estimates • Recent Accounting Pronouncements Overview Business Overview Sleep Number is a wellness technology company and market leader in the design, manufacturing, marketing and distribution of highly innovative sleep solutions.
The Company’s MD&A is presented in the following sections: • Overview • Results of Operations • Liquidity and Capital Resources • Critical Accounting Policies and Estimates • Recent Accounting Pronouncements Business Overview Sleep Number is a wellness technology company and market leader in the design, manufacturing, marketing and distribution of highly innovative sleep solutions.
The Company’s advantaged business model is supported by its consumer innovation strategy: an individualized sleep wellness platform, a network of highly engaged Smart Sleepers, a vertically integrated operating model, and a culture of individuality, with an ambitious vision to become one of the world’s most beloved brands.
The Company’s advantaged business model is supported by its consumer innovation strategy: an individualized, digital sleep wellness platform, a network of highly engaged Smart Sleepers, a vertically integrated operating model and a culture of individuality, with an ambitious vision to become one of the world’s most beloved brands.
Sleep Number’s exclusive distribution meets its customers whenever and wherever they choose – through digital and in-store touchpoints – to provide an exceptional experience and a lifelong relationship. The Company partners with world-leading institutions to bring the power of 24 billion hours of longitudinal sleep data to sleep science and research.
Sleep Number’s exclusive distribution meets its customers whenever and wherever they choose – through digital and in-store touchpoints – to provide an exceptional experience and a lifelong relationship. The Company partners with world-leading institutions to bring the power of 31 billion hours of longitudinal sleep data to sleep science and research.
This Tenth Amendment, among other things: (a) decreased the total aggregate commitment under the Credit Agreement from $825 million to $685 million; (b) decreased the $625 million revolving loan commitment to $485 million; (c) decreased the accordion from $400 million to $342.5 million; (d) increased the Applicable Commitment Fee Rate to 50 basis points when the Net Leverage Ratio is greater than or equal to 3.50 to 1.00 (as each is defined in the Credit Agreement); (e) increased the Applicable Margin by 25 to 75 basis points for each respective range of Net Leverage Ratios (as each is defined in the Credit Agreement); (f) deemed the Company’s Net Leverage Ratio as greater than or equal to 4.00 to 1.00 but less than 4.50 to 1.00 as of the Tenth Amendment effective date to set pricing for the Applicable Commitment Fee Rate and Applicable Margin until receipt of the compliance certificate for the quarterly reporting period ending December 30, 2023; (g) amends the definition of Consolidated EBITDA (as defined in the Credit Agreement) to include cash add backs, capped at $30 million for the quarterly reporting periods ending December 30, 2023, March 30, 2024, June 29, 2024, September 28, 2024, and December 28, 2024 and capped at $20 million for each quarterly reporting period ending thereafter; (h) amends the definitions of each of Net Leverage Ratio and Senior Secured Leverage Ratio (as each is defined in the Credit Agreement) to include the total operating lease liabilities of borrower, as calculated in accordance with ASC 842 accounting guidance (as of the end of the most recently completed quarterly reporting period) replacing the prior language of six multiplied by Consolidated Rent Expense (for the most recently completed four quarterly reporting periods); (i) adjusts the permissible maximum Net Leverage Ratio (as defined in the Credit Agreement) to (I) 5.00 to 1.00 for the quarterly reporting periods ending December 30, 2023 and March 30, 2024, (II) 5.50 to 1.00 for the quarterly reporting period ending June 29, 2024, (III) 5.00 to 1.00 for the quarterly reporting period ending September 28, 2024, (IV) 4.80 to 1.00 for the quarterly reporting period ending December 28, 2024, and (V) 4.00 to 1.00 for each quarterly reporting period occurring thereafter; (j) adjusts the permissible maximum Interest Coverage Ratio (as defined in the Credit Agreement) to (I) 1.50 to 1.00 for the quarterly reporting periods ending December 30, 2023 and March 30, 2024, (II) 1.25 to 1.00 for the quarterly reporting period ending June 29, 2024, (III) 1.50 to 1.00 for the quarterly reporting periods ending September 28, 2024 and December 28, 2024, and (IV) 3.00 to 1.00 for each quarterly reporting period occurring thereafter; and (k) decreased the requisite Net Leverage Ratio from 3.75 to 1.00 down to 3.00 to 1.00 (under the new applicable definitions) before any Acquisitions (with the exception of the Specified Acquisition) or Restricted Payments (as each is defined in the Credit Agreement) may be made.
The amendment, among other things: (a) decreased the total aggregate commitment under the Credit Agreement from $825 million to $685 million ; (b) decreased the $625 million revolving loan commitment to $485 million ; (c) decreased the accordion from $400 million to $343 million ; (d) increased the Applicable Commitment Fee Rate to 50 basis points when the Net Leverage Ratio is greater than or equal to 3.50 to 1.00 (as each is defined in the Credit Agreement); (e) increased the Applicable Margin by 25 to 75 basis points for each respective range of Net Leverage Ratios (as each is defined in the Credit Agreement); (f) deemed the Company’s Net Leverage Ratio as greater than or equal to 4.00 to 1.00 but less than 4.50 to 1.00 as of the amendment effective date to set pricing for the Applicable Commitment Fee Rate and Applicable Margin until receipt of the compliance certificate for the quarterly reporting period ending December 30, 2023; (g) amended the definition of Consolidated EBITDA (as defined in the Credit Agreement) to include cash add backs, capped at $30 million for the quarterly reporting periods ending December 30, 2023, March 30, 2024, June 29, 2024, September 28, 2024, and December 28, 2024 and capped at $20 million for each quarterly reporting period ending thereafter; (h) amended the definitions of each of Net Leverage Ratio and Senior Secured Leverage Ratio (as each is defined in the Credit Agreement) to include the total operating lease liabilities of borrower, as calculated in accordance with ASC 842 accounting guidance (as of the end of the most recently completed quarterly reporting period) replacing the prior language of six multiplied by Consolidated Rent Expense (for the most recently completed four quarterly reporting periods); (i) adjusted the permissible maximum Net Leverage Ratio (as defined in the Credit Agreement) to (I) 5.00 to 1.00 for the quarterly reporting periods ending December 30, 2023 and March 30, 2024, (II) 5.50 to 1.00 for the quarterly reporting period ending June 29, 2024, (III) 5.00 to 1.00 for the quarterly reporting period ending September 28, 2024, (IV) 4.80 to 1.00 for the quarterly reporting period ending December 28, 2024, and (V) 4.00 to 1.00 for each quarterly reporting period occurring thereafter; (j) adjusted the permissible minimum Interest Coverage Ratio (as defined in the Credit Agreement) to (I) 1.50 to 1.00 for the quarterly reporting periods ending December 30, 2023 and March 30, 2024, (II) 1.25 to 1.00 for the quarterly reporting period ending June 29, 2024, (III) 1.50 to 1.00 for the quarterly reporting periods ending September 28, 2024 and December 28, 2024, and (IV) 3.00 to 1.00 for each quarterly reporting period occurring thereafter; and (k) decreased the requisite Net Leverage Ratio from 3.75 to 1.00 down to 3.00 to 1.00 (under the new applicable definitions) before any Acquisitions (with the exception of the Specified Acquisition) or Restricted Payments (as each is defined in the Credit Agreement) may be made.
The Company’s purpose is to improve the health and wellbeing of society through higher quality sleep; to date, it has improved the lives of over 15 million people. Sleep Number’s Smart Sleepers benefit from individualized sleep experiences, night after night, and are experiencing the physical, mental and emotional benefits of life-changing sleep.
The Company’s purpose is to improve the health and wellbeing of society through higher quality sleep; to date, it has improved the lives of approximately 16 million people. Sleep Number’s Smart Sleepers benefit from individualized sleep experiences, night after night, and are experiencing the physical, mental and emotional benefits of life-changing sleep.
Comparison of 2022 and 2021 For a discussion of the Company’s 2022 versus 2021 results, see its 2022 Form 10-K. 46 | 2023 FORM 10-K SLEEP NUMBER CORPORATION Liquidity and Capital Resources Managing the Company’s liquidity and capital resources is an important part of its commitment to deliver superior shareholder value over time.
Comparison of 2023 and 2022 For a discussion of the Company’s 2023 versus 2022 results, see its 2023 Form 10-K. 42 | 2024 FORM 10-K SLEEP NUMBER CORPORATION Liquidity and Capital Resources Managing the Company’s liquidity and capital resources is an important part of its commitment to deliver superior shareholder value over time.
However, if actual results are not consistent with its estimates or assumptions, the Company may be exposed to additional losses or gains in future periods. A 10% change in its sales returns allowance at December 30, 2023 would have affected net (loss) income by approximately $1.7 million in 2023. Recent Accounting Pronouncements See “Part II, Item 8.
However, if actual results are not consistent with its estimates or assumptions, the Company may be exposed to additional losses or gains in future periods. A 10% change in its sales returns allowance at December 28, 2024 would have affected net loss by approximately $1.5 million in 2024 . Recent Accounting Pronouncements See “Part II, Item 8.
Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Note 1, Business and Summary of Significant Accounting Policies - “New Accounting Pronouncements ” for recent accounting pronouncements that may affect the Company’s financial reporting.
Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Note 1 , Business and Summary of Significant Accounting Policies - “ Recently Adopted and Recently Issued Accounting Pronouncements ” for recent accounting pronouncements that may affect the Company’s financial reporting.
The Company’s primary sources of liquidity are cash flows provided by operating activities and cash available under its $685 million revolving credit facility. As of December 30, 2023, the Company did not have any off-balance sheet financing other than its $7 million in outstanding letters of credit.
The Company’s primary sources of liquidity are cash flows provided by operating activities and cash available under its $678 million revolving credit facility. As of December 28, 2024 , the Company did not have any off-balance sheet financing other than its $7 million in outstanding letters of credit.
Research and development expenses Research and development (R&D) expenses decreased by $6 million to $56 million in 2023, compared with $62 million in 2022 on lower outside services and headcount. While the Company’s consumer innovation pipeline remains robust, it is re-prioritizing R&D resources in this highly constrained environment.
Research and development expenses Research and development (R&D) expenses decreased by $11 million to $45 million in 2024 , compared with $56 million in 2023 on lower outside services and headcount. While the Company’s consumer innovation pipeline remains robust, it is re-prioritizing R&D resources in this highly constrained environment.
The cash generated from ongoing operations and cash available under its revolving credit facility are expected to be adequate to maintain operations and fund anticipated expansion, strategic initiatives and contractual obligations such as lease payments and capital commitments for new retail store locations for the foreseeable future.
The cash generated from ongoing operations and cash available under its revolving credit facility are expected to be adequate to maintain operations and fund anticipated expansion, strategic initiatives and contractual obligations such as lease payments and capital commitments for new retail store locations over the next twelve months .
However, if actual results are not consistent with its estimates or assumptions, the Company may be exposed to losses or gains that could be material. A 10% change in its warranty liability at December 30, 2023, would have affected net (loss) income by approximately $0.7 million in 2023.
However, if actual results are not consistent with its estimates or assumptions, the Company may be exposed to losses or gains that could be material. A 10% change in its warranty liability at December 28, 2024 , would have affected net loss by approximately $0.5 million in 2024 .
The G&A expenses rate increased by 0.6 ppt. in 2023, compared with 2022 due to the items discussed above in addition to the deleveraging impact of the 11% net sales decrease.
The G&A expenses rate increased by 1.1 ppt. in 2024 , compared with 2023 due to the items discussed above in addition to the deleveraging impact of the 11% net sales decrease.
A 10% change in its stock-based compensation expense for the year ended December 30, 2023, would have affected net (loss) income by approximately $1.1 million in 2023. 49 | 2023 FORM 10-K SLEEP NUMBER CORPORATION Description Judgments and Uncertainties Effect if Actual Results Differ from Assumptions Warranty Liabilities The Company provides a limited warranty on most of the products it sells.
A 10% change in its stock-based compensation expense for the year ended December 28, 2024 , would have affected net loss by approximately $0.9 million in 2024 . 47 | 2024 FORM 10-K SLEEP NUMBER CORPORATION Description Judgments and Uncertainties Effect if Actual Results Differ from Assumptions Warranty Liabilities The Company provides a limited warranty on most of the products it sells.
Amounts may not add due to rounding differences. 2023 2022 2021 $ % of Net Sales $ % of Net Sales $ % of Net Sales Net sales $ 1,887.5 100.0 % $ 2,114.3 100.0 % $ 2,184.9 100.0 % Cost of sales 799.0 42.3 % 912.0 43.1 % 866.1 39.6 % Gross profit 1,088.5 57.7 % 1,202.3 56.9 % 1,318.8 60.4 % Operating expenses: Sales and marketing 847.4 44.9 % 919.6 43.5 % 905.4 41.4 % General and administrative 146.6 7.8 % 153.3 7.2 % 161.4 7.4 % Research and development 55.8 3.0 % 61.5 2.9 % 58.5 2.7 % Restructuring costs 15.7 0.8 % — — % — — % Total operating expenses 1,065.6 56.5 % 1,134.4 53.7 % 1,125.3 51.5 % Operating income 22.9 1.2 % 67.9 3.2 % 193.5 8.9 % Interest expense, net 42.7 2.3 % 19.0 0.9 % 6.2 0.3 % (Loss) income before income taxes (19.8) (1.0 %) 48.9 2.3 % 187.3 8.6 % Income tax (benefit) expense (4.5) (0.2 %) 12.3 0.6 % 33.5 1.5 % Net (loss) income $ (15.3) (0.8 %) $ 36.6 1.7 % $ 153.7 7.0 % Net (loss) income per share: Basic $ (0.68) $ 1.63 $ 6.40 Diluted $ (0.68) $ 1.60 $ 6.16 Weighted-average number of common shares: Basic 22.4 22.4 24.0 Diluted 22.4 22.9 24.9 The percentage of the Company’s total net sales, by dollar volume, was as follows: 2023 2022 2021 Retail stores 86.8 % 86.3 % 87.1 % Online, phone, chat and other 13.2 % 13.7 % 12.9 % Total Company 100.0 % 100.0 % 100.0 % The components of total net sales change, including comparable net sales changes, were as follows: Net Sales Increase/(Decrease) 2023 2022 2021 Retail comparable-store sales (1) (12 %) (8 %) 19 % Online, phone and chat (1) (15 %) 4 % 4 % Total Retail comparable sales change (1) (12 %) (6 %) 17 % Net opened/closed stores, other and 53rd week 1 % 3 % 1 % Total Company (11 %) (3 %) 18 % ____________________ (1) Stores are included in the comparable-store calculation in the 13th full month of operations.
Amounts may not add due to rounding differences. 2024 2023 2022 $ % of Net Sales $ % of Net Sales $ % of Net Sales Net sales $ 1,682.3 100.0% $ 1,887.5 100.0 % $ 2,114.3 100.0 % Cost of sales 679.5 40.4% 799.0 42.3 % 912.0 43.1 % Gross profit 1,002.8 59.6% 1,088.5 57.7 % 1,202.3 56.9 % Operating expenses: Sales and marketing 766.6 45.6% 847.4 44.9 % 919.6 43.5 % General and administrative 150.0 8.9% 146.6 7.8 % 153.3 7.2 % Research and development 45.3 2.7% 55.8 3.0 % 61.5 2.9 % Restructuring costs 18.1 1.1% 15.7 0.8 % — — % Total operating expenses 979.9 58.2% 1,065.6 56.5 % 1,134.4 53.7 % Operating income 22.9 1.4% 22.9 1.2 % 67.9 3.2 % Interest expense, net 48.4 2.9% 42.7 2.3 % 19.0 0.9 % (Loss) income before income taxes (25.5) (1.5%) (19.8) (1.0 %) 48.9 2.3 % Income tax (benefit) expense (5.2) (0.3%) (4.5) (0.2 %) 12.3 0.6 % Net (loss) income $ (20.3) (1.2%) $ (15.3) (0.8 %) $ 36.6 1.7 % Net (loss) income per share: Basic $ (0.90) $ (0.68) $ 1.63 Diluted $ (0.90) $ (0.68) $ 1.60 Weighted-average number of common shares: Basic 22.6 22.4 22.4 Diluted 22.6 22.4 22.9 The percentage of the Company’s total net sales, by dollar volume, was as follows: 2024 2023 2022 Retail stores 87.6 % 86.8 % 86.3 % Online, phone, chat and other 12.4 % 13.2 % 13.7 % Total Company 100.0 % 100.0 % 100.0 % The components of total net sales change, including comparable net sales changes, were as follows: Net Sales Increase/(Decrease) 2024 2023 2022 Retail comparable-store sales (1) (9%) (12%) (8%) Online, phone and chat (1) (17%) (15%) 4% Total Retail comparable sales change (1) (10%) (12%) (6%) Net opened/closed stores and other (1%) 1% 3% Total Company (11%) (11%) (3%) ____________________ (1) Stores are included in the comparable-store calculation in the 13th full month of operations.
Net cash used in investing activities was $58 million for the fiscal year ended December 30, 2023, compared with $71 million in 2022. Investing activities in 2023 included $57 million of property and equipment purchases, compared with $69 million last year.
Net cash used in investing activities was $26 million for the fiscal year ended December 28, 2024 , compared with $58 million in 2023 . Investing activities in 2024 included $24 million of property and equipment purchases, compared with $57 million last year.
The 2023 gross profit rate increased to 57.7% of net sales, compared with 56.9% for the prior-year period.
The 2024 gross profit rate increased to 59.6% of net sales, compared with 57.7% for the prior-year period.
As of December 30, 2023, the Company had $540 million of borrowings under its revolving credit facility, $7 million in outstanding letters of credit and net liquidity available under the credit facility of $138 million.
As of December 28, 2024 , the Company had $547 million of borrowings under its revolving credit facility, $7 million in outstanding letters of credit and net liquidity available under the credit facility of $124 million .
Total Retail smart bed unit sales decreased 16% compared with the prior year. Average revenue per smart bed unit in Total Retail increased by 7% to $5,755, compared with $5,403 in the prior-year period. Gross profit Gross profit for 2023 of $1.09 billion decreased by $114 million, or 9%, compared with $1.20 billion in 2022.
Total Retail smart bed unit sales decreased 12% compared with the prior year. Average revenue per smart bed unit in Total Retail increased to $5,818 , compared with $5,755 in the prior-year period. Gross profit Gross profit for 2024 of $1.0 billion decreased by $86 million , or 8% , compared with $1.09 billion in 2023 .
Amounts may not add due to rounding differences: 2023 2022 Total cash (used in) provided by: Operating activities $ (9,028) $ 36,138 Investing activities (58,352) (70,607) Financing activities 68,127 33,872 Net increase (decrease) in cash and cash equivalents $ 747 $ (597) Cash used in operating activities for the fiscal year ended December 30, 2023 was $9 million compared with net cash provided by operating activities of $36 million for the fiscal year ended December 31, 2022.
Amounts may not add due to rounding differences: 2024 2023 Total cash provided by (used in): Operating activities $ 27,143 $ (9,028) Investing activities (26,291) (58,352) Financing activities (1,441) 68,127 Net (decrease) increase in cash and cash equivalents $ (589) $ 747 Cash provided by operating activities for the fiscal year ended December 28, 2024 was $27 million , compared with net cash used in operating activities of $9 million for the fiscal year ended December 30, 2023 .
The foregoing description of the Tenth Amendment is qualified in its entirety by reference to the complete terms of the Tenth Amendment, which is filed as an exhibit to this Quarterly Report on Form 10-Q.
The foregoing description of the Tenth Amendment is qualified in its entirety by reference to the complete terms of the Tenth Amendment, which is filed as an exhibit to this Annual Report on Form 10-K. The Company amended the Credit Agreement on March 3, 2025.
The $7 million decrease in G&A expenses mainly consisted of the following: (i) a $8.2 million reduction in employee compensation on lower headcount; (ii) a $3.1 million benefit from favorable legal settlements (iii) a $0.9 million reduction in professional and consulting fees; (iv) a $0.7 million decrease in travel and training expenses; and (v) a $1.2 million decrease in other miscellaneous expenses; partially offset by (vi) a $4.0 million increase in company-wide, performance-based incentive compensation due to the achievement of first half of the fiscal year performance targets in the current year; and (vi) a $3.5 million increase in technology investments.
The $3 million increase in G&A expenses mainly consisted of the following: (i) an increase in miscellaneous other expense of $4.8 million, which benefited during the prior year from legal and insurance settlements of $4.1 million; (ii) $4.6 million increase in company- wide, performance-based incentive compensation due to the achievement of fiscal year performance targets in the current year; partially offset by (iii) a $5.9 million reduction in employee compensation on lower headcount; and (iv) a $1.0 million benefit from a decrease in other occupancy expenses.
Income tax (benefit) expense Income tax benefit was $4 million for the year ended December 30, 2023, compared with income tax expense of $12 million for the same period one year ago. The effective income tax rate for the year ended December 30, 2023 was 22.6% compared with 25.1% for the year ended December 31, 2022.
Income tax (benefit) expense Income tax benefit was $5 million for the year ended December 28, 2024 , compared with $4 million for the same period one year ago. The effective income tax rate for the year ended December 28, 2024 was 20.2% compared with 22.6% for the year ended December 30, 2023 .
The $227 million net sales decrease compared with the same period one year ago was primarily comprised of: (i) a $206 million decrease in the Company’s Total Retail comparable net sales; (ii) a $42 million decrease from phone, online and chat; offset by (iii) a $21 million increase resulting from net store openings.
The $205 million net sales decrease compared with the same period one year ago was primarily comprised of: (i) a $144 million decrease in the Company’s Total Retail comparable net sales; (ii) a $41 million decrease from phone, online and chat; (iii) a $21 million decrease resulting from net opened/closed stores in the past 12 months; (iv) offset by a $1 million increase in wholesale/other.
These actions support $40 to $45 million of incremental operating expense reductions in 2024. Interest expense, net Interest expense, net increased to $43 million for the year ended December 30, 2023, compared with $19 million for the same period one year ago. The $24 million increase was primarily related to a higher weighted-average interest rate during 2023 compared with 2022.
Interest expense, net Interest expense, net increased to $48 million for the year ended December 28, 2024 , compared with $43 million for the same period one year ago. The $6 million increase was primarily related to a higher weighted-average interest rate during 2024 compared with 2023 .
During the fiscal year ended December 30, 2023, the Company repurchased $4 million of its common stock (in connection with the vesting of employee restricted stock grants), compared with $64 million in 2022 (based on settlement dates, $55 million under its Board-approved share repurchase program and $9 million in connection with the vesting of employee restricted stock grants).
During 2024 , the Company repurchased $1 million of its stock compared with $4 million (based on settlement dates, in connection with the vesting of employee restricted stock awards ) in 2023 . The Company made no share repurchases under its Board-approved share repurchase program in either fiscal year .
The sales and marketing expense rate increased to 44.9% of net sales, compared with 43.5% for the same period one year ago.
Sales and marketing expenses Sales and marketing expenses decreased to $767 million in 2024 , compared with $847 million last year. The sales and marketing expense rate increased to 45.6% of net sales, compared with 44.9% for the same period one year ago.
Total Retail comparable sales in 2020 have been adjusted to remove the estimated impact of the additional week. 44 | 2023 FORM 10-K SLEEP NUMBER CORPORATION Other sales metrics were as follows: 2023 2022 2021 Average sales per store ($ in thousands) (1)(4) $ 2,853 $ 3,281 $ 3,600 Average sales per square foot (1)(4) $ 926 $ 1,081 $ 1,212 Stores > $2 million in net sales (2)(4) 65 % 76 % 84 % Stores > $3 million in net sales (2)(4) 24 % 36 % 48 % Average revenue per smart bed unit – Total Retail (3) $ 5,755 $ 5,403 $ 5,102 ____________________ (1) Trailing-twelve months Total Retail comparable sales per store open at least one year.
Stores that have been remodeled or repositioned within the same shopping center remain in the comparable-store base. 40 | 2024 FORM 10-K SLEEP NUMBER CORPORATION Other sales metrics were as follows: 2024 2023 2022 Average sales per store ($ in thousands) (1) $ 2,601 $ 2,853 $ 3,281 Average sales per square foot (1) $ 841 $ 926 $ 1,081 Stores > $2 million in net sales (2) 57 % 65 % 76 % Stores > $3 million in net sales (2) 18 % 24 % 36 % Average revenue per smart bed unit – Total Retail (3) $ 5,818 $ 5,755 $ 5,403 ____________________ (1) Trailing-twelve months Total Retail comparable sales per store open at least one year.
The number of retail stores operating was as follows: 2023 2022 2021 Beginning of period 670 648 602 Opened 36 49 77 Closed (34) (27) (31) End of period 672 670 648 Comparison of 2023 and 2022 Net sales Net sales in 2023 decreased 11% to $1.9 billion, compared with $2.1 billion in 2022.
The number of retail stores operating was as follows: 2024 2023 2022 Beginning of period 672 670 648 Opened 12 36 49 Closed (44) (34) (27) End of period 640 672 670 Comparison of 2024 and 2023 Net sales Net sales in 2024 decreased 11% to $1.7 billion , compared with $1.9 billion in 2023 due to t he ongoing weakness in the mattress industry and consumers continuing to scrutinize their spending.
At December 30, 2023, the company’s leverage ratio as defined in the credit agreement was 4.1x versus the permissible net leverage ratio of 48 | 2023 FORM 10-K SLEEP NUMBER CORPORATION 5.0x, the weighted-average interest rate on borrowings under the credit facility was 8.5% and the Company was in compliance with all financial covenants.
At December 28, 2024 , the company’s leverage ratio as defined in the Credit Agreement was 4.2 x versus the permissible net leverage ratio of 4.8x, the weighted-average interest rate on borrowings under the credit facility was 7.6% and the Company was in compliance with all financial covenants.
Net loss per diluted share decreased to $0.68, compared with net income per diluted share of $1.60 per diluted share in 2022. • The Company achieved a return on invested capital (Adjusted ROIC) of 7.8% in 2023, compared with 17.6% in 2022. • Cash used in operating activities in 2023 decreased to $9 million, compared with cash provided by operating activities of $36 million for the prior year.
Net loss per diluted share increased to $0.90 , compared with $0.68 in 2023 . • The Company’s adjusted return on invested capital (Adjusted ROIC) was 7.6% in 2024 , compared with 7.8% in 2023 . • The Company generated $27 million in cash from operating activities in 2024 , compared with cash used in operating activities of $9 million in 2023 .
The 0.8 ppt. increase in the gross profit rate was mainly due to: (i) favorable pricing actions taken over the past twelve months that increased the rate by 2.0 ppt.; (ii) improvement in commodity prices and operating efficiencies increased the rate by 1.5 ppt.; partially offset by (iii) product mix of FlexFit smart adjustable bases, pressured the rate by 1.6 ppt.; (iv) higher returns and warranty costs, primarily related to the returnability of the integrated adjustable base as part of the Climate360 smart bed, decreased the rate by 0.7 ppt; and (v) lower delivered smart bed volume deleveraged the rate by 0.3 ppt.
The 1.9 ppt. increase in the gross profit rate was mainly due to: (i) year-over-year product cost reductions through value engineering and ongoing supplier negotiations that increased the rate by 1.1 ppt; (ii) efficiency gains in home delivery and logistics operations increased the rate by 1.0 ppt; (iii) favorable pricing actions taken over the past twelve months that increased the rate by 0.8 ppt; (iv) lower returns costs increased the rate by 0.3 ppt; partially offset by (v) product mix of FlexFit smart adjustable bases, which pressured the rate by 0.8 ppt; and (vi) lower delivered smart bed volume deleveraged the rate by 0.5 ppt.
(2) Trailing-twelve months for stores open at least one year (excludes Online, Phone and Chat sales). (3) Represents Total Retail net sales divided by Total Retail smart bed units. (4) Fiscal 2020 included 53 weeks, as compared to 52 weeks in fiscal 2023, 2022 and 2021. The additional week in 2020 was in the fiscal fourth quarter.
(2) Trailing-twelve months for stores open at least one year (excludes Online, Phone and Chat sales). (3) Represents Total Retail net sales divided by Total Retail smart bed units.
Critical Accounting Policies and Estimates The Company’s consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP). In connection with the preparation of its financial statements, the Company is required to make estimates and assumptions about future events and apply judgments that affect the reported amounts of assets, liabilities, sales, expenses and the related disclosures.
In connection with the preparation of its financial statements, the Company is required to make estimates and assumptions about future events and apply judgments that affect the reported amounts of assets, liabilities, sales, expenses and the related disclosures. Predicting future events is inherently an imprecise activity and as such requires the use of judgment.
On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that its financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from the Company’s assumptions and estimates, and such differences could be material.
However, because future events and their effects cannot be determined with certainty, actual results could differ from the Company’s assumptions and estimates, and such differences could be material.
Net cash provided by financing activities was $68 million for the fiscal year ended December 30, 2023, compared with $34 million in 2022.
Net cash used in financing activities was $1 million for the fiscal year ended December 28, 2024 , compared with net cash provided by financing activities of $68 million in 2023 . The decrease in cash provided by financing activities is primarily due to a $74 million decrease in cash provided by short-term borrowings.
Predicting future events is inherently an imprecise activity and as such requires the use of judgment. The Company bases its assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time its consolidated financial statements are prepared.
The Company bases its assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time its consolidated financial statements are prepared. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that its financial statements are presented fairly and in accordance with GAAP.
The Company generates revenue by marketing and selling its innovative smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). 42 | 2023 FORM 10-K SLEEP NUMBER CORPORATION Results of Operations Fiscal 2023 Summary Financial highlights for fiscal 2023 were as follows: • Net sales for 2023 decreased 11% to $1.9 billion, compared with $2.1 billion in 2022.
The Company generates revenue by marketing and selling its innovative smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail).
Restructuring costs In fiscal 2023, the Company incurred $15.7 million of restructuring costs. In light of the demand trajectory change in August 2023, the Company initiated business restructuring actions. Charges comprised of contract termination costs, severance and employee-related benefits, professional fees and other, and asset impairment charges.
Charges incurred related to this initiative were comprised of contract termination costs, severance and employee-related benefits, professional fees and other, and asset impairment charges and are included in the restructuring costs line in the Company’s consolidated statement of operations.
Financing activities for both years reflect the cash proceeds from the exercise of employee stock options. 47 | 2023 FORM 10-K SLEEP NUMBER CORPORATION In the second quarter of fiscal 2022, the Company suspended share repurchases under its Board-approved share repurchase program.
The Company also paid $2 million for debt issuance costs associated with the Credit Agreement amendment incurred during 2023 . Financing activities for 2023 reflect the cash proceeds from the minimal exercise of employee stock options. There was no option exercise activity during 2024 . The Company suspended share repurchases under its Board-approved share repurchase program during fiscal 2022.
For additional details, see the components of total net sales growth on page 44 . • Sales per store in 2023 (sales for stores open at least one year, Total Retail, including Online, Phone and Chat) on a trailing twelve-month basis totaled $2.9 million, 13.0% lower than 2022. • 2023 operating income of $23 million decreased by $45 million compared with $68 million in the prior year, driven by the decrease in net sales and lower gross margin; partially offset by a $69 million reduction in total operating expense that included $16 million of restructuring costs in the fourth quarter.
For additional details, see the components of total net sales change on page 39 . • Average sales per store (sales for stores open at least one year, Total Retail, including online, phone and chat) for the year ended December 28, 2024 totaled $2.6 million , compared with $2.9 million for the same period last year. • Operating income for both 2024 and 2023 was $23 million .
The Company’s 2023 operating income rate decreased to 1.2% of net sales, compared with 3.2% of net sales in 2022. Its 2023 operating income rate was impacted by the deleveraging impact of the 11% decrease in net sales. • Net loss in 2023 of $15 million, compared with net income of $37 million in 2022.
Operating income was pressured by the decrease in net sales that was partially offset by the Company’s $86 million reduction in total operating expense that included $18 million of restructuring costs during 2024 . The Company’s 2024 operating income rate increased to 1.4% of net sales, compared with 1.2% of net sales in 2023 .
General and administrative expenses General and administrative (G&A) expenses decreased $7 million to $147 million in 2023, compared with $153 million in the prior year, and increased to 7.8% of net sales, compared with 7.2% of net sales one year ago.
The current-year sales and marketing expense rate increase of 0.7 ppt. was primarily due to the deleveraging impact of an 11% net sales decrease offset by a 10% decrease in expenses including a 9% lower media spend. 41 | 2024 FORM 10-K SLEEP NUMBER CORPORATION General and administrative expenses General and administrative (G&A) expenses increased $3 million to $150 million in 2024 , compared with $147 million in the prior year, and increased to 8.9% of net sales, compared with 7.8% of net sales one year ago.
Purchases of property and equipment for 2023 was $57 million, compared with $69 million in 2022. • The Company ended 2023 with $540 million of borrowings under its credit facility, compared with $460 million at the end of 2022. Net liquidity available under the credit facility was $138 million at December 30, 2023.
Purchases of property and equipment for 2024 was $24 million , compared with $57 million in 2023 . • Free cash flow provided $4 million for the year ended December 28, 2024 , compared with using $66 million for the same period last year. • The Company ended 2024 with $547 million of borrowings under its revolving credit facility, compared with $540 million at the end of 2023 . 39 | 2024 FORM 10-K SLEEP NUMBER CORPORATION The following table sets forth the Company’s results of operations expressed as dollars and percentages of net sales.
Significant changes in cash and cash equivalents during 2023 included $73 million increase in short-term borrowings, which were offset by $57 million of cash used to purchase property and equipment, $9.0 million of cash used by operating activities and $4 million of cash used to repurchase the Company’s common stock (in connection with the vesting of employee restricted stock grants).
Significant changes in cash and cash equivalents during 2024 included $27 million of cash provided by operating activities, which was offset by $24 million of cash used to purchase property and equipment and $3 million used in the issuance of a note receivable. The following table summarizes the Company’s cash flows (dollars in millions).
Significant components of the $45 million year-over-year decrease in cash from operating activities included: (i) a $52 million decrease in net (loss) income in 2023 compared with 2022; (ii) $32 million fluctuation in customer prepayments due to the timing of customer deliveries; (iii) a $25 million change in prepaid expenses and other current assets primarily due to amount and timing of rebate payments; (iv) a $24 million fluctuation in accounts payable due to lower expenses in the current year’s fourth quarter and timing of payments; and (v) a $17 million fluctuation in accrued compensation and benefits primarily related to year-over-year changes in company-wide performance-based compensation that was earned in 2021 and paid in the first quarter of 2022, compared with no company-wide performance-based compensation earned in 2022 and paid in the first quarter of 2023.
Significant components of the $36 million year-over-year increase in cash from operating activities included: (i) a $22 million fluctuation in customer prepayments due to the timing of customer deliveries; (ii) a $14 million fluctuation in inventory due to lower sales volumes and operational improvements; (iii) a $13 million fluctuation in accounts payable due to lower expenses in the current year’s fourth quarter and timing of payments; (iv) a $10 million fluctuation in accounts receivable due to lower sales volumes and timing of orders at the end of fiscal 2024 compared with 2023 ; partially offset by (v) a $15 million fluctuation in other accruals and liabilities due to timing of store buyout costs; (vi) an $8 million decrease in depreciation and amortization due to recent lower capital spending levels and restructuring related fixed asset impairments.
See Notes 7, Leases , and 13, Commitments and Contingencies , for further details on the Company’s contractual obligations. Cash and cash equivalents totaled $2.5 million and $1.8 million at December 30, 2023 and December 31, 2022, respectively.
Cash and cash equivalents totaled $2.0 million and $2.5 million at December 28, 2024 and December 30, 2023 , respectively.